Funded by the German Free State of Saxony, the SaxoCOV project consortium was established on September 1, 2020. Under the direction of the Fraunhofer Institute for Cell Therapy and Immunology IZI, six non-university, university and clinical partners from Saxony are involved.
The consortium conducts a Saxony-wide field study on the spread of SARS-CoV-2. It is supported by two further, non-Saxon research institutes. The aim is to create a scientific instrument to follow the development of the SARS-CoV-2 epidemic in the German Free State of Saxony on multiple levels. The field study will on the one hand serve to monitor the effectiveness of governmental measures to contain the pandemic and on the other hand support the detection and limitation of outbreak scenarios. The sound knowledge base thus created will enable predictions to be made about future developments and help to assess the effectiveness of containment measures.
The samples and data collected in the field study will also be used in an accompanying research study to answer further research questions. In particular, the question is pressing as to which causes are responsible for the very different mild or aggressive course of the disease and whether there are parameters with which these different courses can be predicted.
More information: www.saxocov.de (in German only)